Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5

Molecular Endocrinology

Volumn 20, Issue 9, 2006, Pages 2173-2186

  Ning, Yun ^a   Schuller, Alwin G P ^a   Bradshaw, Sheri ^a   Rotwein, Peter ^b   Ludwig, Thomas ^c   Frystyk, Jan ^d   Pintar, John E ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5;

ADIPOCYTE; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CELL SIZE; CONTROLLED STUDY; GLUCOSE METABOLISM; GROWTH RETARDATION; HOMEOSTASIS; INSULIN RELEASE; INSULIN SENSITIVITY; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE; HOMEOSTASIS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; ISLETS OF LANGERHANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MUTATION; ORGAN SIZE;

ANIMALIA; MAMMALIA;

EID: 33747822985     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0196     Document Type: Article

References (59)

1. Le Roith D 2003 The insulin-like growth factor system. Exp Diabesity Res 4:205-212
2. Murphy LJ 2003 The role of the insulin-like growth factors and their binding proteins in glucose homeostasis. Exp Diabesity Res 4:213-224
3. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
4. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
5. Baxter RC 2000 Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278:E967-E976
6. Mohan S, Baylink DJ 2002 IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 175:19-31
7. Murphy LJ 1998 Insulin-like growth factor-binding proteins: functional diversity or redundancy? J Mol Endocrinol 21:97-107
8. Clemmons DR, Busby W, Clarke JB, Parker A, Duan C, Nam TJ 1998 Modifications of insulin-like growth factor binding proteins and their role in controlling IGF actions. Endocr J 45(Suppl):S1-S8
9. Spagnoli A, Hwa V, Horton WA, Lunstrum GP, Roberts Jr CT, Chiarelli F, Torello M, Rosenfeld RG 2001 Antiproliferative effects of insulin-like growth factor-binding protein-3 in mesenchymal chondrogenic cell line RCJ3.1C5.18. Relationship to differentiation stage. J Biol Chem 276:5533-5540
10. Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts Jr CT, Fontana JA 1994 Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol 158:69-78
11. Ernst M, Rodan GA 1990 Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127:807-814
12. Angelloz-Nicoud P, Harel L, Binoux M 1996 Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases. Growth Regul 6:130-136
13. Clark RG, Mortensen D, Reifsynder D, Mohler M, Etcheverry T, Mukku V 1993 Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat. Growth Regul 3:50-52
14. Hamon GA, Hunt TK, Spencer EM 1993 In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds. Growth Regul 3:53-56
15. Miyakoshi N, Richman C, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S 2001 Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest 107:73-81
16. Stewart CE, Bates PC, Calder TA, Woodall SM, Pell JM 1993 Potentiation of insulin-like growth factor-I (IGF-I) activity by an antibody: supportive evidence for enhancement of IGF-I bioavailability in vivo by IGF binding proteins. Endocrinology 133:1462-1465
17. Zapf J 1997 Total and free IGF serum levels. Eur J Endocrinol 136:146-147
18. Martin JL, Baxter RC 1992 Insulin-like growth factor binding protein-3: biochemistry and physiology. Growth Regul 2:88-99
19. Boisclair YR, Rhoads RP, Ueki I, Wang J, Ooi GT 2001 The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. J Endocrinol 170:63-70
20. Lee CY, Rechler MM 1995 Formation of 150-kDa binary complexes of insulin-like growth factor binding protein-3 and the acid-labile subunit in vitro and in vivo. Prog Growth Factor Res 6:241-251
21. Rajkumar K, Krsek M, Dheen ST, Murphy LJ 1996 Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. J Clin Invest 98:1818-1825
22. Di Cola G, Cool MH, Accili D 1997 Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J Clin Invest 99:2538-2544
23. Schneider MR, Lahm H, Wu M, Hoeflich A, Wolf E 2000 Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins. FASEB J 14:629-640
24. Wang J, Niu W, Witte DP, Chernausek SD, Nikiforov YE, Clemens TL, Sharifi B, Strauch AR, Fagin JA 1998 Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle α-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology 139:2605-2614
25. Wood TL, Rogler LE, Czick ME, Schuller AG, Pintar JE 2000 Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. Mol Endocrinol 14:1472-1482
26. Silha JV, Murphy LJ 2002 Insights from insulin-like growth factor binding protein transgenic mice. Endocrinology 143:3711-374
27. Chen JW, Ledet T, Orskov H, Jessen N, Lund S, Whittaker J, De Meyts P, Larsen MB, Christiansen JS, Frystyk J 2003 A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am J Physiol Endocrinol Metab 284:E1149-E1155
28. Bratanova-Tochkova TK, Cheng H, Daniel S, Gunawardana S, Liu YJ, Mulvaney-Musa J, Schermerhorn T, Straub SG, Yajima H, Sharp GW 2002 Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 51(Suppl 1):S83-S90
29. Kulkarni RN 2004 The islet β-cell. Int J Biochem Cell Biol 36:365-371
30. Yamauchi T, Tobe K, Tamemoto H, Ueki K, Kaburagi Y, Yamamoto-Honda R, Takahashi Y, Yoshizawa F, Aizawa S, Akanuma Y, Sonenberg N, Yazaki Y, Kadowaki T 1996 Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol Cell Biol 16:3074-3084
31. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF 1998 Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904
32. Cheatham B, Kahn CR 1995 Insulin action and the insulin signaling network. Endocr Rev 16:117-142
33. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
34. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B 1997 The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332:F105-F126
35. Le Roith D, Kim H, Fernandez AM, Accili D 2002 Inactivation of muscle insulin and IGF-I receptors and insulin responsiveness. Curr Opin Clin Nutr Metab Care 5:371-375
36. Wang J, Zhou J, Powell-Braxton L, Bondy C 1999 Effects of Igf1 gene deletion on postnatal growth patterns. Endocrinology 140:3391-3394
37. Domene HM, Bengolea SV, Jasper HG, Boisclair YR 2005 Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse. J Endocrinol Invest 28:43-46
38. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D 2002 Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781
39. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D 2001 Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50:1110-1118
40. Baserga R 1994 Oncogenes and the strategy of growth factors. Cell 79:927-930
41. Hu X, Jin L, Feng L 2004 Erk1/2 but not PI3K pathway is required for neurotrophin 3-induced oligodendrocyte differentiation of post-natal neural stem cells. J Neurochem 90:1339-1347
42. Freeman SM, Whartenby KA 2004 The role of the mitogen-activated protein kinase cellular signaling pathway in tumor cell survival and apoptosis. Drug News Perspect 17:237-242
43. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, Montgomery C, Schwartz RJ 1995 Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270:12109-12116
44. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA 1993 IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617
45. Ogus S, Ke Y, Qiu J, Wang B, Chehab FF 2003 Hyperleptinemia precipitates diet-induced obesity in transgenic mice overexpressing leptin. Endocrinology 144:2865-2869
46. Porksen N, Hussain MA, Bianda TL, Nyholm B, Christiansen JS, Butler PC, Veldhuis JD, Froesch ER, Schmitz O 1997 IGF-I inhibits burst mass of pulsatile insulin secretion at supraphysiological and low IGF-I infusion rates. Am J Physiol 272:E352-E358
47. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR 1998 A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559-569
48. Leahy JL, Vandekerkhove KM 1990 Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology 126:1593-1598
49. Funaki M, Randhawa P, Janmey PA 2004 Separation of insulin signaling into distinct GLUT4 translocation and activation steps. Mol Cell Biol 24:7567-7577
50. Gual P, Le Marchand-Brustel Y, Tanti J 2003 Positive and negative regulation of glucose uptake by hyperosmotic stress. Diabetes Metab 29:566-575
51. Hill DJ, Petrik J, Arany E, McDonald TJ, Delovitch TL 1999 Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from pre-diabetic non-obese diabetic mice. J Endocrinol 161:153-165
52. Giannoukakis N, Mi Z, Rudert WA, Gambotto A, Trucco M, Robbins P 2000 Prevention of β cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I. Gene Ther 7:2015-2022
53. Rossetti L, Frontoni S, Dimarchi R, DeFronzo RA, Giaccari 1991 Metabolic effects of IGF-I in diabetic rats. Diabetes 40:444-448
54. Simpson HL, Umpleby AM, Russell-Jones DL 1998 Insulin-like growth factor-I and diabetes. A review. Growth Horm IGF Res 8:83-95
55. Guler HP, Zapf J, Froesch ER 1987 Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 317:137-140
56. Lewitt MS, Denyer GS, Cooney GJ, Baxter RC 1991 Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology 129:2254-2256
57. Frystyk J, Skjaerbaek C, Dinesen B, Orskov H 1994 Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 348:185-191
58. Ekins R 1990 Measurement of free hormones in blood. Endocr Rev 11:5-46
59. Juul A, Skakkebaek NE 1997 Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. J Pediatr 130:197-204